My NCBI | Sign In
RSS Settings
  • Search: Bani-Sadr Firouzé[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 20

    1.

    [ANRS HC 02 RIBAVIC: summary and recommandations]

    Bani-Sadr F.

    Gastroenterol Clin Biol. 2009 Mar;33 Suppl 2:S104-5. French. No abstract available. PMID: 19375036 [PubMed - in process]Related articles

    2.

    Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy.

    Bani-Sadr F, Lapidus N, Rosenthal E, Gerard L, Foltzer A, Perronne C, Cacoub P, Pol S, Carrat F; and the ANRS HC02-Ribavic Study Team.

    J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):429-30. No abstract available. PMID: 19322037 [PubMed - indexed for MEDLINE]Related articles

    3.

    Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients?

    Bani-Sadr F, Bedossa P, Rosenthal E, Merrien D, Perre P, Lascoux-Combe C, Cacoub P, Perronne C, Pol S; ANRS HC02-Ribavic Study Team.

    J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):234-6. No abstract available. PMID: 19155771 [PubMed - indexed for MEDLINE]Related articles

    4.

    Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.

    Piroth L, Carrat F, Larrat S, Goderel I, Martha B, Payan C, Lunel-Fabiani F, Bani-Sadr F, Perronne C, Cacoub P, Pol S, Morand P.

    J Hepatol. 2008 Dec;49(6):892-8. Epub 2008 Jul 17.PMID: 18752863 [PubMed - indexed for MEDLINE]Related articles

    5.

    Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients.

    Carrat F, Bedossa P, Lunel-Fabiani F, Morand P, Pialoux G, Piroth L, Salmon-Céron D, Bani-Sadr F, Perronne C, Cacoub P, Pol S.

    AIDS. 2008 Jul 31;22(12):1513-5.PMID: 18614875 [PubMed - indexed for MEDLINE]Related articles

    6.

    Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.

    Bani-Sadr F, Goderel I, Lapidus N, Driss H, Simon A, Rosenthal E, Morand P, Lunel-Fabiani F, Pol S, Cacoub P, Perronne C, Carrat F; ANRS HC02 - RIBAVIC Study Team.

    AIDS. 2008 Jul 11;22(11):1385-7. No abstract available. PMID: 18580626 [PubMed - indexed for MEDLINE]Related articles

    7.

    Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients.

    Bani-Sadr F, Miailhes P, Rosenthal E, Yazdanpanah Y, Boyer L, Zucman D, Cacoub P, Perronne C, Pol S, Carrat F; ANRS HC02 - Ribavic Study Team.

    AIDS. 2008 Jun 19;22(10):1234-6. No abstract available. PMID: 18525274 [PubMed - indexed for MEDLINE]Related articles

    8.

    Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.

    Bani-Sadr F, Lapidus N, Bedossa P, De Boever CM, Perronne C, Halfon P, Pol S, Carrat F, Cacoub P; French National Agency for Research on AIDS; Viral Hepatitis-HC02-Ribavic Study Team.

    Clin Infect Dis. 2008 Mar 1;46(5):768-74.PMID: 18248298 [PubMed - indexed for MEDLINE]Related articles

    9.

    High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?

    Bani-Sadr F, Goderel I, Morand P, Payan C, Lunel F, Pol S, Perronne C, Carrat F, Cacoub P.

    AIDS. 2007 Jul 31;21(12):1645-8.PMID: 17630563 [PubMed - indexed for MEDLINE]Related articles

    10.

    Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?

    Bani-Sadr F, Denoeud L, Morand P, Lunel-Fabiani F, Pol S, Cacoub P, Perronne C, Carrat F; Agence Nationale pour la Recherche contre le SIDA et les Hépatites Virales HC02-Ribavic Study Team.

    J Acquir Immune Defic Syndr. 2007 May 1;45(1):123-5. No abstract available. PMID: 17460476 [PubMed - indexed for MEDLINE]Related articles

    11.

    Reactivation of hepatitis B virus replication during peginterferon-ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies.

    Chakvetadze C, Bani-Sadr F, Le Pendeven C, Lamontagne F, Vincensini JP, Pialoux G.

    AIDS. 2007 Jan 30;21(3):393-4. No abstract available. PMID: 17255759 [PubMed - indexed for MEDLINE]Related articles

    12.

    Limb swelling with hypereosinophilia.

    Chakvetadze C, Bani-Sadr F, Develoux M, Le Breton C, Pialoux G.

    Lancet. 2006 Sep 23;368(9541):1126. No abstract available. PMID: 16997667 [PubMed - indexed for MEDLINE]Related articles

    13.

    Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.

    Bani-Sadr F, Carrat F, Bedossa P, Piroth L, Cacoub P, Perronne C, Degott C, Pol S; ANRS HC02 - Ribavic Study team.

    AIDS. 2006 Feb 28;20(4):525-31.PMID: 16470116 [PubMed - indexed for MEDLINE]Related articles

    14.

    Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment.

    Bani-Sadr F, Carrat F, Rosenthal E, Piroth L, Morand P, Lunel-Fabiani F, Bonarek M, Colin de Verdiere N, Pialoux G, Cacoub P, Pol S, Perronne C; ANRS HC02-Ribavic Study Team.

    Clin Infect Dis. 2005 Dec 15;41(12):1806-9. Epub 2005 Nov 11.PMID: 16288408 [PubMed - indexed for MEDLINE]Related articles

    15.

    Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy.

    Bani-Sadr F, Carrat F, Pol S, Hor R, Rosenthal E, Goujard C, Morand P, Lunel-Fabiani F, Salmon-Ceron D, Piroth L, Pialoux G, Bentata M, Cacoub P, Perronne C; ANRS Hc02-Ribavic Study Team.

    J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):47-52.PMID: 16123681 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

    Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, Morand P, Goujard C, Pialoux G, Piroth L, Salmon-Céron D, Degott C, Cacoub P, Perronne C; ANRS HCO2 RIBAVIC Study Team.

    JAMA. 2004 Dec 15;292(23):2839-48.PMID: 15598915 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection]

    Bani-Sadr F.

    Gastroenterol Clin Biol. 2003 May;27(5):528-33. Review. French. No abstract available. PMID: 12843917 [PubMed - indexed for MEDLINE]Related articles

    18.

    Reactivation of HBV replication in HIV-HBV infected patients.

    Bani-Sadr F, Maillard A, Ponscarme D, Scieux C, Molina JM.

    Am J Med. 2003 Jun 15;114(9):768-9. No abstract available. PMID: 12829207 [PubMed - indexed for MEDLINE]Related articles

    19.

    Relapse of Kaposi's sarcoma in HIV-infected patients switching from a protease inhibitor to a non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimen.

    Bani-Sadr F, Fournier S, Molina JM.

    AIDS. 2003 Jul 4;17(10):1580-1. No abstract available. PMID: 12824806 [PubMed - indexed for MEDLINE]Related articles

    20.

    Acute Guillain-Barré syndrome during the chronic phase of HIV infection and dramatic improvement under highly active antiretroviral therapy.

    Bani-Sadr F, Neuville S, Crassard I, Guihot A, Molina JM.

    AIDS. 2002 Jul 26;16(11):1562. No abstract available. PMID: 12131198 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity